Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
GV-971
Shanghai University of Traditional Chinese Medicine
Alzheimer Disease
1 trial -
JS001
Shanghai University of Traditional Chinese Medicine
Triple-Negative Breast Cancer
1 trial -
Sodium Thiosulfate Injection
Shanghai University of Traditional Chinese Medicine
Hepatoblastoma
1 trial -
AK0529
Shanghai University of Traditional Chinese Medicine
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
1 trial -
EMB-01
Shanghai University of Traditional Chinese Medicine
Neoplasms
1 trial -
Furmonertinib
Shanghai University of Traditional Chinese Medicine
Lung Adenocarcinoma Stage III
1 trial -
JMT108
Shanghai University of Traditional Chinese Medicine
Unresectable Locally Advanced or Metastatic Melanoma
1 trial -
MRG003
Shanghai University of Traditional Chinese Medicine
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
1 trial -
SR419
Shanghai University of Traditional Chinese Medicine
Peripheral Neuropathic Pain
1 trial -
TQC2731 injection
Shanghai University of Traditional Chinese Medicine
Chronic Obstructive Pulmonary Disease
1 trial -
TQH2722 injection
Shanghai University of Traditional Chinese Medicine
Seasonal Allergic Rhinitis
1 trial -
cis Platinum/Carboplatin, Pemetrexed Disodium
Shanghai University of Traditional Chinese Medicine
Chemotherapy, Adjuvant
1 trial -
9MW3811 injection
Shanghai University of Traditional Chinese Medicine
Pulmonary Fibrosis
1 trial -
Donepezil Dihydroxynaphthalate for Injection
Shanghai University of Traditional Chinese Medicine
Alzheimer Disease
1 trial -
HB0056
Shanghai University of Traditional Chinese Medicine
Healthy
1 trial -
JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells)
Shanghai University of Traditional Chinese Medicine
Diffuse Large B Cell Lymphoma
1 trial -
MWN109 tablet
Shanghai University of Traditional Chinese Medicine
Overweight or Obesity
1 trial -
Qing'E pill
Shanghai University of Traditional Chinese Medicine
Menopause
1 trial -
Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo
Shanghai University of Traditional Chinese Medicine
Healthy
1 trial -
Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
Shanghai University of Traditional Chinese Medicine
Osteosarcoma
1 trial -
SCT-001 CAR-T cells
Shanghai University of Traditional Chinese Medicine
Ovarian Cancer
1 trial -
SYHA1813 oral solution (2.0g:25mg)
Shanghai University of Traditional Chinese Medicine
Healthy Participants
1 trial -
TQB2825 Injection (Subcutaneous Injection)
Shanghai University of Traditional Chinese Medicine
CD20-positive Hematological Malignancies
1 trial -
YZJ-1139 tablets
Shanghai University of Traditional Chinese Medicine
Insomnia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources